Skip to main content

Advertisement

SpringerLink
Log in

Interventional CT: 30 years’ experience

  • Published:
European Radiology Supplements

Abstract

CT-guided procedures remain an important tool for diagnosis and tissue acquisition for primary diagnosis and molecular/tissue correlation. New imaging devices such as MDCT and PET/CT will improve diagnosis but percutaneous procedures will be needed to confirm and support new molecular and DNA treatments. Coagulopathic patients can be treated with LIBE a new method to prevent bleeding. Vasoactive drugs can be used to improve differentiation of malignant and benign diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Radiology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA

    John R. Haaga

Authors
  1. John R. Haaga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John R. Haaga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haaga, J.R. Interventional CT: 30 years’ experience. Eur Radiol Suppl 15 (Suppl 4), d116–d120 (2005). https://doi.org/10.1007/s10406-005-0130-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10406-005-0130-9

Keywords

Search

Navigation